Palisade Asset Management’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-3,626
Closed -$228K 205
2026
Q1
$228K Buy
3,626
+6
+0.2% +$480 0.02% 185
2025
Q4
$345K Hold
3,620
0.03% 165
2025
Q3
$353K Buy
3,620
+12
+0.3% +$1.24K 0.03% 167
2025
Q2
$388K Hold
3,608
0.04% 162
2025
Q1
$364K Buy
3,608
+80
+2% +$8.06K 0.04% 161
2024
Q4
$315K Hold
3,528
0.03% 170
2024
Q3
$296K Buy
+3,528
New +$278K 0.03% 176
2024
Q2
Sell
-2,528
Closed -$173K 223
2024
Q1
$173K Buy
+2,528
New +$163K 0.02% 203
2017
Q4
Sell
-11,900
Closed -$347K 163
2017
Q3
$347K Hold
11,900
0.06% 117
2017
Q2
$330K Hold
11,900
0.06% 117
2017
Q1
$296K Hold
11,900
0.05% 120
2016
Q4
$257K Hold
11,900
0.05% 126
2016
Q3
$283K Hold
11,900
0.05% 118
2016
Q2
$278K Hold
11,900
0.05% 121
2016
Q1
$224K Buy
+11,900
New +$209K 0.04% 127
2015
Q4
Sell
-10,500
Closed -$172K 130
2015
Q3
$172K Hold
10,500
0.04% 130
2015
Q2
$186K Hold
10,500
0.04% 134
2015
Q1
$186K Buy
+10,500
New +$166K 0.04% 135

Other funds holding BSX

Palisade Asset Management's BSX Position: Q2 2026 in Review

Palisade Asset Management sold out of Boston Scientific (BSX) in Q2 2026, closing a stake of 3,626 shares — an estimated $228K sold.

Palisade Asset Management first reported a position in BSX in Q1 2015 and held it in 18 quarters. The position peaked at $388K in Q2 2025. 303 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Palisade Asset Management reported no remaining Boston Scientific position as of Q2 2026 after selling out during the quarter.
  • Palisade Asset Management sold 3,626 Boston Scientific shares in Q2 2026, an estimated $228K.
  • Palisade Asset Management first reported a position in Boston Scientific in Q1 2015 and held it in 18 quarters.
  • Palisade Asset Management's Boston Scientific position peaked at $388K in Q2 2025.
  • 303 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Palisade Asset Management's 13F filing for Q2 2026, filed 20 Jul 2026.